
Opinion|Videos|May 14, 2024
Strategies to Enhance CDK4/6 Inhibitor Adherence in mBC
Heather Moore, BCOP, CPP, PharmD, discusses patient adherence to CDK4/6 inhibitors in clinical practice, emphasizing the importance of educating patients on drug efficacy and potential toxicities, monitoring for adverse events, and following up with patients to ensure better adherence.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
2
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
3
Oral GLP-1 Orforglipron Is Approved for Obesity
4
Navigating the New Era of Hemophilia Care: Insights From the Pharmacy Times Peer Exchange
5





































































































































